Published: 13 sept. 2024(Updated: 13 sept. 2024)
•30 min
•30 min read
•Lena Mahmoudi Azar, Elif Karaman, Burcu Beyaz, Işılay Göktan, Alp Ertunga Eyüpoğlu, Seda Kizilel, Batu Erman, Ahmet Gül, Serdar UysalExpression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system
In a new study, published on Springer Link, researchers produced a more stable and cost-effective interleukin-1 receptor antagonist (IL-1Ra) using Aspergillus oryzae. This alternative to E. coli-expressed IL-1Ra offers improved stability and bioactivity, making it a promising option for industrial-scale production. Explore the full findings and implications for therapeutic manufacturing.